Can boosting hemoglobin help kidney transplant patients feel better and protect their kidneys?
NCT ID NCT00396435
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether raising hemoglobin levels with a drug called epoetin (Neorecormon) could improve quality of life and slow kidney function decline in people who had a kidney transplant and now have chronic graft dysfunction. About 128 adults who had a transplant 1 to 20 years ago and had reduced kidney function took part. They were split into two groups: one aimed for a higher hemoglobin target, the other for a lower one. The study measured quality of life after 6 months and kidney function over 24 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Epoetin (Neorecormon)
What this could lead to
If successful, this could show that managing anemia with epoetin improves daily well-being and helps preserve kidney function in transplant patients.
What could go wrong
This is a completed Phase 4 trial with 128 participants, so results are limited in scope. The intervention may not significantly slow kidney decline or improve quality of life for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Clermont Ferrand - Hôpital Gabriel Monpied
Clermont-Ferrand, 63003, France
-
CHU de Tours - Hôpital Bretonneau
Tours, 37044, France
-
Hôpital Brabois
Vandœuvre-lès-Nancy, 54500, France
-
Hôpital Calmette
Lille, 59037, France
-
Hôpital Civil
Strasbourg, 67091, France
-
Hôpital Clémenceau
Caen, 14033, France
-
Hôpital Dupuytren
Limoges, 87052, France
-
Hôpital Foch
Suresnes, 92151, France
-
Hôpital Henri Mondor
Créteil, 94010, France
-
Hôpital Maison Blanche
Reims, 51092, France
-
Hôpital Necker - Enfants Malades
Paris, 75743, France
-
Hôpital Pasteur
Nice, 06002, France
-
Hôpital Pellegrin
Bordeaux, 33076, France
-
Hôpital Pontchaillou
Rennes, 35033, France
-
Hôpital Rangueil
Toulouse, 33076, France
-
Hôpital Sud
Amiens, 80000, France
-
Hôpital de Bois Guillaume
Bois-Guillaume, 76230, France
-
Hôpital de la Conception
Marseille, 13385, France
-
Hôpital de la Milétrie
Poitiers, 86021, France
-
Hôpital de la Tronche
Grenoble, 38043, France